UC Irvine UC Irvine Electronic Theses and Dissertations

Total Page:16

File Type:pdf, Size:1020Kb

UC Irvine UC Irvine Electronic Theses and Dissertations UC Irvine UC Irvine Electronic Theses and Dissertations Title Functional, Safe, and Effective Mitigation of Radiation-Induced Cognitive Deficits Using Stem Cell-Derived Extracellular Vesicles in a Wild-Type Rodent Model Permalink https://escholarship.org/uc/item/1585t77j Author Leavitt, Ron Joshua Publication Date 2019 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, IRVINE DISSERTATION TITLE: Functional, Safe, and Effective Mitigation of Radiation-Induced Cognitive Deficits Using Stem Cell-Derived Extracellular Vesicles in a Wild-Type Rodent Model Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Environmental Health Sciences by Ron Joshua Leavitt Dissertation Committee: Professor Charles Limoli, Chair Professor Ulrike Luderer Professor Robert Phalen Associate Professor Mathew Blurton-Jones Associate Professor Kim Green Defended: December 12 th , 2019 Introduction © 2018 Taylor & Francis Group LLC. DEDICATION For Alex Of course it is happening inside your head, Harry, but why on earth should that mean that it is not real? JK Rowling Harry Potter and The Deathly Hallows ii TABLE OF CONTENTS Page LIST OF FIGURES v LIST OF TABLES vii ACKNOWLEDGMENTS viii CURRICULUM VITAE ix ABSTRACT OF THE DISSERTATION x INTRODUCTION AND LITERATURE REVIEW 1 Extracellular Vesicles 4 EV as Therapeutic Agents in Regenerative Medicine 12 CHAPTER 1: EV Study in Wild-Type Mice with Retro-orbital Delivery 17 Introduction 17 Cognitive Behavioral Testing Data 21 EV Tracking 28 Immunohistochemical Staining 30 Discussion 33 CHAPTER 2: EV Study Molecular Analyses and EV Cargo Analysis 38 Introduction 38 RNA Sequencing 41 EV Cargo Analysis 51 Discussion 53 CHAPTER 3: miR-124 Overexpression Study 56 Introduction 56 Cognitive Behavioral Testing Data 58 Immunohistochemical Staining 61 Expression Analysis 63 Discussion and Ongoing Research 66 CHAPTER 4: Methodology 69 SUMMARY AND CONCLUSIONS 79 REFERENCES 82 APPENDIX A: ZetaView® Particle Measurements 92 iii APPENDIX B: Additional Behavioral Testing Figures 101 APPENDIX C: Raw Cognitive Behavioral Testing Data 103 APPENDIX D: PSD-95 Staining Results 129 APPENDIX E: RNA-seq Data Tables 130 APPENDIX F: Primer Design and Efficiency Testing 131 APPENDIX G: miRNA Detection qPCR Data 134 iv LIST OF FIGURES Page Figure 1 EV treatment in cranially-irradiated athymic nude rats ameliorated radiation-induced neuroinflammation and damage to neuronal structure. 13 Figure 1.1 Stem cell-derived EV protect against radiation-induced cognitive dysfunction at 5 weeks and 6 months post irradiation. 23 Figure 1.2 EV-treated mice exhibit decreased anxiety at 5 weeks and 6 months post irradiation 25 Figure 1.3 Fear extinction training 26 Figure 1.4 Stem cell-derived EV tracked to the host hippocampus following retro-orbital or intra-hippocampal injections 29 Figure 1.5 Stem cell-derived EV treatment reduces neuroinflammation in the hippocampus following irradiation 31 Figure 1.6 Model for Radiation-Induced Brain Injury and Rescue 36 Figure 2.1 Principal Component Analysis (PCA) is not able to separate experimental groups 41 Figure 2.2 Hierarchical Clustering shows little similarity between samples of each experimental group 42 Figure 2.3 Gene Ontology enrichment suggests that inflammatory processes may be important factors in radiation-induced cognitive deficits 43 Figure 2.4 Relative expression of miR-124 target genes is decreased in hippocampal tissue overexpressing miR-124 50 Figure 3.1 miR-124 overexpression in vivo shows functional mitigation of radiation-induced cognitive dysfunction 59 Figure 3.2 CD68 staining volume decreased in both irradiated groups compared to the unirradiated ones 62 Figure 3.3 Select expression profiles of whole hippocampal tissues from wild-type mice from the miR-124 overexpression study 65 v LIST OF TABLES Page Table 1 miRNAs associated with EV from specific cell types and known functions based on peer-reviewed literature. 11 Table 2 The advantages and disadvantages of stem cell therapy versus EV therapy. 14 Table 2.1 Top 30 differentially expressed genes in the control group compared to the IRR group 46 Table 2.2 Top 30 differentially expressed genes in the EV-treated groups compared to the IRR group 47 Table 2.3 Top 30 differentially expressed genes in the control group compared to the EV-treated groups 48 vi ACKNOWLEDGMENTS I would like to express huge thanks and appreciation to my committee chair, Professor Charles Limoli. He took me in during the darkest hour of my graduate student experience when no one else would and provided me with a lab environment where I could learn, grow, and thrive. None of this would have been possible without his kindness and generosity, not to mention his direction and mentorship. I would like to thank my “outside” committee members, Associate Professors Mathew Blurton-Jones and Kim Green for valuable insights on the project, both during the advancement meeting and in helping design the miR-124 AAV project. I would like to also thank Professor Ulrike Luderer, who not only recruited me to UC Irvine, but had been the Environmental Health Sciences program director for most of my time here. She has been an invaluable source of institutional knowledge and advice. I would like to thank Dr. Lianghao Ding and Dr. Michael Story from University of Texas Southwestern Medical Center for running the miRNA microarray experiment. I would like to thank the entire Limoli lab for help, showing me where things are located, occasional junk food, and support throughout the process. Specifically, I would like to thank lab members Dr. Janet Baulch and Assistant Professor Munjal Acharya for giving so much of their precious time to an annoying grad student and playing an indispensable role in his training. Finally, I would like to thank my friends and family for sticking with me for this long (extremely long) and difficult process. This especially includes my brand new wife Alexandria who has suffered through five years of this and in many ways put her life on hold so that I could finish my degree. I also thank Taylor & Francis Online for permission to include the Introduction of my dissertation, which was originally published in International Journal of Radiation Biology. This work was supported by the Defense Threat Reduction Agency (HDTRA 1-13-1-0022, to Charles Limoli), NIH NINDS R01 NS074388 (to Charles Limoli), California Institute for Regenerative Medicine (DISC1-10079, to Janet Baulch), UCI Research Seed Funding Program (to Janet Baulch). vii CURRICULUM VITAE Ron Joshua Leavitt 2007 B.S. in Molecular, Cell, and Developmental Biology, University of California, Los Angeles 2008-13 Research Associate, Zymo Research Corp., Irvine, CA 2019 Ph.D. in Environmental Health Sciences, University of California, Irvine FIELD OF STUDY Radiotherapy and Cognitive Function PUBLICATIONS Leavitt, R.J., Limoli, C.L., & Baulch, J.E. (2018). miRNA-based therapeutic potential of stem cell-derived extracellular vesicles: a safe cell-free treatment to ameliorate radiation-induced brain injury. International Journal of Radiation Biology, 25:1-8. Than, N.G., Romero, R., Tarca, A.L., Kekesi, K.A., Xu, Y., Juhasz, K., Bhatti, G., Leavitt, R.J., … & Papp, Z. (2018). Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia. Frontiers in Immunology, 9:1661. Chamorro-Garcia, R., Diaz-Castillo, C., Shoucri, B.M., Käch, H., Leavitt, R., Shioda, T., & Blumberg B. (2017). Ancestral perinatal obesogen exposure results in a transgenerational thrifty phenotype in mice. Nature Communications, 8(1):2012. Than, N. G., Romero, R., Xu, Y., Erez, O., Xu, Z., Bhatti, G., Leavitt, R., … & Bohn, H. (2014). Evolutionary origins of the placental expression of Chromosome 19 cluster galectins and their complex dysregulation in preeclampsia. Placenta, 35(11):855–865. Ashktorab, H., Daremipouran, M., Goel, A., Varma, S., Leavitt, R., Sun, X., & Brim, H. (2014). DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia. Epigenetics, 9(4):503–512. viii ABSTRACT OF THE DISSERTATION Functional, Safe, and Effective Mitigation of Radiation-Induced Cognitive Deficits Using Stem Cell-Derived Extracellular Vesicles in a Wild-Type Rodent Model By Ron Joshua Leavitt Doctor of Philosophy in Environmental Health Sciences University of California, Irvine, 2019 Professor Charles Limoli, Chair Radiation-induced learning and memory problems are reported in more than half of survivors of cancers treated with cranial radiotherapy, representing an unmet clinical need in a growing population. Cell-free therapy employing extracellular vesicles (EV) derived from stem cells has been pioneered to address this problem in an immunocompromised rodent model. However, no study has yet demonstrated efficacy of this cell-free treatment in wild-type animals or determined the mechanism. This research has sought to address both of those shortcomings, as well as introduce a more clinically palatable delivery method to improve safety while maintaining efficacy. A large cohort of wild-type mice was used to determine the efficacy of post-irradiation EV treatment in wild-type animals and retro-orbital sinus injection. At five weeks and six months post-irradiation, animals were subjected to a battery of cognitive behavioral tests. Follow up studies analyzed tissues via RNA-seq, RT-qPCR, and immunohistochemical staining. Behavioral testing
Recommended publications
  • A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array
    UC Davis UC Davis Previously Published Works Title A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array. Permalink https://escholarship.org/uc/item/0pk953bj Journal Frontiers in genetics, 9(JAN) ISSN 1664-8021 Authors Schurz, Haiko Kinnear, Craig J Gignoux, Chris et al. Publication Date 2018 DOI 10.3389/fgene.2018.00678 Peer reviewed eScholarship.org Powered by the California Digital Library University of California fgene-09-00678 January 16, 2019 Time: 18:45 # 1 ORIGINAL RESEARCH published: 18 January 2019 doi: 10.3389/fgene.2018.00678 A Sex-Stratified Genome-Wide Association Study of Tuberculosis Using a Multi-Ethnic Genotyping Array Haiko Schurz1,2*, Craig J. Kinnear1, Chris Gignoux3, Genevieve Wojcik4, Paul D. van Helden1, Gerard Tromp1,2,5, Brenna Henn6, Eileen G. Hoal1 and Marlo Möller1 1 DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, 2 South African Tuberculosis Bioinformatics Initiative, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, 3 Colorado Center for Personalized Medicine, Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States, 4 Department of Genetics, Stanford University, Stanford, CA, United States, 5 Centre for Bioinformatics and Computational Biology, Stellenbosch University, Cape Town, South Africa, 6 Department of Anthropology, UC Davis Genome Center, University of California, Davis, Davis, CA, United States Edited by: Zané Lombard, University of the Witwatersrand, Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a complex disease with a South Africa known human genetic component.
    [Show full text]
  • Arnau Soler2019.Pdf
    This thesis has been submitted in fulfilment of the requirements for a postgraduate degree (e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following terms and conditions of use: This work is protected by copyright and other intellectual property rights, which are retained by the thesis author, unless otherwise stated. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the author. The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the author. When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given. Genetic responses to environmental stress underlying major depressive disorder Aleix Arnau Soler Doctor of Philosophy The University of Edinburgh 2019 Declaration I hereby declare that this thesis has been composed by myself and that the work presented within has not been submitted for any other degree or professional qualification. I confirm that the work submitted is my own, except where work which has formed part of jointly-authored publications has been included. My contribution and those of the other authors to this work are indicated below. I confirm that appropriate credit has been given within this thesis where reference has been made to the work of others. I composed this thesis under guidance of Dr. Pippa Thomson. Chapter 2 has been published in PLOS ONE and is attached in the Appendix A, chapter 4 and chapter 5 are published in Translational Psychiatry and are attached in the Appendix C and D, and I expect to submit chapter 6 as a manuscript for publication.
    [Show full text]
  • <Abstract Centered> an ABSTRACT of the THESIS OF
    AN ABSTRACT OF THE DISSERTATION OF Michael Austin Garland for the degree of Doctor of Philosophy in Toxicology presented on June 14, 2019. Title: Transcriptomic Approaches for Discovering Regenerative and Developmental Regulatory Networks in Zebrafish Abstract approved: _____________________________________________________________________ Robert L. Tanguay Zebrafish are capable of fully regenerating organs and tissue such as their caudal fin, which is similar to a human regrowing an arm or a leg. In contrast, most mammals including humans have a greatly reduced capacity for wound healing. The ability of zebrafish to undergo this regenerative process, called epimorphic regeneration, hinges on the capacity to form a blastema at the wound site. The blastema quickly recapitulates the developmental processes involved in complex tissue formation to restore lost or damaged tissue. One key mechanism for inducing blastema formation is global repression of genes involved in tissue differentiation and maintenance. Induction of repressive factors, such as microRNAs (miRNAs), are involved in reprogramming cells during epimorphic regeneration. The upstream mechanism by which zebrafish undergo epimorphic regeneration remains elusive. Furthermore, while focus is shifting toward regulatory RNAs such as miRNAs, the full complement of their repressive activities is unknown. We took a transcriptomics approach to investigating epimorphic regeneration and fin development. Parallel sequencing of total RNA and small RNA samples was performed on regenerating fin tissue at 1 day post-amputation (dpa). Most miRNAs had increased expression, consistent with global repression of genes involved in cell specialization during de-differentiation. We identified predicted interactions between miRNAs and genes involved in transcriptional regulation, chromatin modification, and developmental signaling. miR-146a and miR-146b are anti- inflammatory miRNAs that were predicted to target eya4, which is involved in chromatin remodeling and innate immunity.
    [Show full text]
  • PRODUCTS and SERVICES Target List
    PRODUCTS AND SERVICES Target list Kinase Products P.1-11 Kinase Products Biochemical Assays P.12 "QuickScout Screening Assist™ Kits" Kinase Protein Assay Kits P.13 "QuickScout Custom Profiling & Panel Profiling Series" Targets P.14 "QuickScout Custom Profiling Series" Preincubation Targets Cell-Based Assays P.15 NanoBRET™ TE Intracellular Kinase Cell-Based Assay Service Targets P.16 Tyrosine Kinase Ba/F3 Cell-Based Assay Service Targets P.17 Kinase HEK293 Cell-Based Assay Service ~ClariCELL™ ~ Targets P.18 Detection of Protein-Protein Interactions ~ProbeX™~ Stable Cell Lines Crystallization Services P.19 FastLane™ Structures ~Premium~ P.20-21 FastLane™ Structures ~Standard~ Kinase Products For details of products, please see "PRODUCTS AND SERVICES" on page 1~3. Tyrosine Kinases Note: Please contact us for availability or further information. Information may be changed without notice. Expression Protein Kinase Tag Carna Product Name Catalog No. Construct Sequence Accession Number Tag Location System HIS ABL(ABL1) 08-001 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) ABL(ABL1) BTN BTN-ABL(ABL1) 08-401-20N Full-length 2-1130 NP_005148.2 N-terminal DYKDDDDK Insect (sf21) ABL(ABL1) [E255K] HIS ABL(ABL1)[E255K] 08-094 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) HIS ABL(ABL1)[T315I] 08-093 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) ABL(ABL1) [T315I] BTN BTN-ABL(ABL1)[T315I] 08-493-20N Full-length 2-1130 NP_005148.2 N-terminal DYKDDDDK Insect (sf21) ACK(TNK2) GST ACK(TNK2) 08-196 Catalytic domain
    [Show full text]
  • Page 1 Exploring the Understudied Human Kinome For
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022277; this version posted June 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Exploring the understudied human kinome for research and therapeutic opportunities Nienke Moret1,2,*, Changchang Liu1,2,*, Benjamin M. Gyori2, John A. Bachman,2, Albert Steppi2, Rahil Taujale3, Liang-Chin Huang3, Clemens Hug2, Matt Berginski1,4,5, Shawn Gomez1,4,5, Natarajan Kannan,1,3 and Peter K. Sorger1,2,† *These authors contributed equally † Corresponding author 1The NIH Understudied Kinome Consortium 2Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts 02115, USA 3 Institute of Bioinformatics, University of Georgia, Athens, GA, 30602 USA 4 Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA 5 Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27599, USA Key Words: kinase, human kinome, kinase inhibitors, drug discovery, cancer, cheminformatics, † Peter Sorger Warren Alpert 432 200 Longwood Avenue Harvard Medical School, Boston MA 02115 [email protected] cc: [email protected] 617-432-6901 ORCID Numbers Peter K. Sorger 0000-0002-3364-1838 Nienke Moret 0000-0001-6038-6863 Changchang Liu 0000-0003-4594-4577 Ben Gyori 0000-0001-9439-5346 John Bachman 0000-0001-6095-2466 Albert Steppi 0000-0001-5871-6245 Page 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022277; this version posted June 30, 2020.
    [Show full text]
  • Biomarkers and Genetics of Canine Visceral Haemangiosarcoma
    Biomarkers and genetics of canine visceral haemangiosarcoma Patharee Oungsakul Doctor of Veterinary Medicine, Master of Veterinary Studies 0000-0003-4523-3484 A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in Year 2020 School of Veterinary Science Abstract Visceral haemangiosarcoma (HSA) is a vascular endothelial cell cancer that arises in internal organs, especially in the spleen. HSA carries a very poor prognosis but is also difficult to diagnose. Therefore, dogs with HSA symptoms are often euthanized without full investigation. The goal of the thesis was to improve the diagnosis and prevention of this cancer by exploring several HSA biomarkers. The thesis comprises four independent biomarker studies regarding glycoproteins, genetics and Infrared spectral markers. The aim of the first study (chapter 2) was to validate the candidates for canine visceral HSA serum biomarkers, by performing tissue immuno- and lectin-labelling of HSA (n = 32) and HSA-like (n=26) formalin-fixed paraffin-embedded (FFPE) tissues with C7 (component complement 7), MGAM (maltase-glucoamylase), VTN (vitronectin) antibodies and DSA (Datura stramonium), WGA (Wheat germ agglutinin), SNA (Sambucus nigra) and PSA (Pisum sativum)lectins. The results showed lectin/immuno-positive signal on HSA cells, endothelial cell of the veins and arteries. IHC and LHC signal intensities were heterogeneous across the tissue types, diagnosis groups (HSA vs HSA-like) and tissue markers. A semi-quantitative assay was applied to assess and compare the levels of IHC/LHC signal intensities of each marker. Among the candidates tested, complement component 7 (C7) and DSA binding glycoproteins were considered the most promising tissue markers as they demonstrated the ability to distinguish HSA tissue from HSA-like tissues (e.g.
    [Show full text]
  • Us 2018 / 0305689 A1
    US 20180305689A1 ( 19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2018 /0305689 A1 Sætrom et al. ( 43 ) Pub . Date: Oct. 25 , 2018 ( 54 ) SARNA COMPOSITIONS AND METHODS OF plication No . 62 /150 , 895 , filed on Apr. 22 , 2015 , USE provisional application No . 62/ 150 ,904 , filed on Apr. 22 , 2015 , provisional application No. 62 / 150 , 908 , (71 ) Applicant: MINA THERAPEUTICS LIMITED , filed on Apr. 22 , 2015 , provisional application No. LONDON (GB ) 62 / 150 , 900 , filed on Apr. 22 , 2015 . (72 ) Inventors : Pål Sætrom , Trondheim (NO ) ; Endre Publication Classification Bakken Stovner , Trondheim (NO ) (51 ) Int . CI. C12N 15 / 113 (2006 .01 ) (21 ) Appl. No. : 15 /568 , 046 (52 ) U . S . CI. (22 ) PCT Filed : Apr. 21 , 2016 CPC .. .. .. C12N 15 / 113 ( 2013 .01 ) ; C12N 2310 / 34 ( 2013. 01 ) ; C12N 2310 /14 (2013 . 01 ) ; C12N ( 86 ) PCT No .: PCT/ GB2016 /051116 2310 / 11 (2013 .01 ) $ 371 ( c ) ( 1 ) , ( 2 ) Date : Oct . 20 , 2017 (57 ) ABSTRACT The invention relates to oligonucleotides , e . g . , saRNAS Related U . S . Application Data useful in upregulating the expression of a target gene and (60 ) Provisional application No . 62 / 150 ,892 , filed on Apr. therapeutic compositions comprising such oligonucleotides . 22 , 2015 , provisional application No . 62 / 150 ,893 , Methods of using the oligonucleotides and the therapeutic filed on Apr. 22 , 2015 , provisional application No . compositions are also provided . 62 / 150 ,897 , filed on Apr. 22 , 2015 , provisional ap Specification includes a Sequence Listing . SARNA sense strand (Fessenger 3 ' SARNA antisense strand (Guide ) Mathew, Si Target antisense RNA transcript, e . g . NAT Target Coding strand Gene Transcription start site ( T55 ) TY{ { ? ? Targeted Target transcript , e .
    [Show full text]
  • A Resource for Exploring the Understudied Human Kinome for Research and Therapeutic
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022277; this version posted March 11, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. A resource for exploring the understudied human kinome for research and therapeutic opportunities Nienke Moret1,2,*, Changchang Liu1,2,*, Benjamin M. Gyori2, John A. Bachman,2, Albert Steppi2, Clemens Hug2, Rahil Taujale3, Liang-Chin Huang3, Matthew E. Berginski1,4,5, Shawn M. Gomez1,4,5, Natarajan Kannan,1,3 and Peter K. Sorger1,2,† *These authors contributed equally † Corresponding author 1The NIH Understudied Kinome Consortium 2Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts 02115, USA 3 Institute of Bioinformatics, University of Georgia, Athens, GA, 30602 USA 4 Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA 5 Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC 27599, USA † Peter Sorger Warren Alpert 432 200 Longwood Avenue Harvard Medical School, Boston MA 02115 [email protected] cc: [email protected] 617-432-6901 ORCID Numbers Peter K. Sorger 0000-0002-3364-1838 Nienke Moret 0000-0001-6038-6863 Changchang Liu 0000-0003-4594-4577 Benjamin M. Gyori 0000-0001-9439-5346 John A. Bachman 0000-0001-6095-2466 Albert Steppi 0000-0001-5871-6245 Shawn M.
    [Show full text]
  • The Cancer Genome Atlas Dataset-Based Analysis of Aberrantly Expressed Genes by Geneanalytics in Thymoma Associated Myasthenia Gravis: Focusing on T Cells
    2323 Original Article The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells Jianying Xi1#, Liang Wang1#, Chong Yan1, Jie Song1, Yang Song2, Ji Chen2, Yongjun Zhu2, Zhiming Chen2, Chun Jin3, Jianyong Ding3, Chongbo Zhao1,4 1Department of Neurology, 2Department of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China; 3Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200030, China; 4Department of Neurology, Jing’an District Centre Hospital of Shanghai, Fudan University, Shanghai 200040, China Contributions: (I) Conception and design: J Xi, L Wang, C Zhao; (II) Administrative support: J Xi, L Wang, C Zhao; (III) Provision of study materials or patients: Y Song, Y Zhu, J Chen, Z Chen, C Jin, J Ding; (IV) Collection and assembly of data: C Jin, J Ding; (V) Data analysis and interpretation: C Yan, J Song; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Chongbo Zhao. Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China. Email: [email protected]. Background: Myasthenia gravis (MG) is a group of autoimmune disease which could be accompanied by thymoma. Many differences have been observed between thymoma-associated MG (TAMG) and non-MG thymoma (NMG). However, the molecular difference between them remained unknown. This study aimed to explore the differentially expressed genes (DEGs) between the two categories and to elucidate the possible pathogenesis of TAMG further. Methods: DEGs were calculated using the RNA-Sequencing data from 11 TAMG and 10 NMG in The Cancer Genome Atlas (TCGA) database.
    [Show full text]
  • Supplemental Figure 1
    A BCD6 35 80 1.0 3 Thr Ala 0.4 Thr Ala 30 0.8 60 4 0.3 2 25 0.6 40 20 0.2 0.4 1 2 20 intake(g)Food Body weight(g) 15 0.1 0.2 Serum TSH (ng/ml) T4 plasmaT4 levels (ng/ml) plasma levelsT3 (ng/ml) 1/V 10 0.0 0 0.0 0 5 10 15 Thr Ala Thr Ala Thr Ala -1.0 -0.5 0.5 1.0 1.5 2.0 Thr Ala Thr Ala Age (weeks) 1/[T4] (nM) dark light (fmols/min/mg ptn) (fmols/min/mg -1 Ala Thr IKMN O Femur 16.5 0.55 1100 0.24 E F 16.0 1050 0.22 G H 0.50 Thr92‐D2 15.5 1000 0.20 Ala92‐D2 0.45 15.0 950 0.18 (mgHAcm-3) Femur volume 0.40 14.5 900 0.16 Cortical thickness Femur length (mm) length Femur Bone MineralDensity 14.0 0.35 850 0.14 Thr Ala Thr Ala Thr Ala Thr Ala JLPQR Vertebrae 4.6 5.5 0.070 0.35 4.4 5.0 0.065 0.30 **P<0.01 0.060 4.2 *** 4.5 0.055 0.25 4.0 4.0 0.050 0.20 3.8 3.5 Trabecular number 0.045 Trabecular spacing Trabecular thickness Vertebral height (mm) height Vertebral 3.6 3.0 0.040 0.15 Thr Ala Thr Ala Thr Ala Thr Ala Figure S1: Additional phenotype of the Ala92‐Dio2 mouse.
    [Show full text]
  • Identification of Potential and Novel Target Genes in Pituitary Prolactinoma by Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423732; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis 1 2 3 4* Vikrant Ghatnatti , Basavaraj Vastrad , Swetha Patil , Chanabasayya Vastrad , Iranna Kotturshetti5 1. Dept of Endocrinology/Medicine, J N Medical College, Belagavi 590010, Karnataka, India. 2. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 3. Dept of Obstetrics and Gynaecology, J N Medical college, Belagavi 590010, Karnataka, India. 4. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India. 5. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron 562209, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India Abstract bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423732; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Pituitary prolactinoma is one of the most complicated and fatally pathogenic pituitary adenomas. Therefore, there is an urgent need to improve our understanding of the underlying molecular mechanism that drives the initiation, progression, and metastasis of pituitary prolactinoma. The aim of the present study was to identify the key genes and signaling pathways associated with pituitary prolactinoma using bioinformatics analysis. Transcriptome microarray dataset GSE119063 was acquired from Gene Expression Omnibus datasets, which included 5 pituitary prolactinoma samples and 4 normal pituitaries samples.
    [Show full text]
  • Supplementary Material
    Supplementary Material Table of Contents Figure S1 ................................................................................................................................................................................... 2 Figure S2 ................................................................................................................................................................................... 3 Figure S3 ................................................................................................................................................................................... 4 Table S1. 225 Autophagy Modulators. .................................................................................................................................... 5 Table S2. 993 known targets and 12 predicted targets of autophagy modulators ................................................................. 9 Table S3. 368 Predicted ATG interactions and experimental validation ............................................................................ 33 Table S4. GO annotation enrichments based on ATG targets.............................................................................................. 39 Table S5. Pathways enriched in targets of autophagy modulators, corresponding targets, and autophagy modulators . 42 Supplementary References ................................................................................................................................................... 65 1 Figure S1. Distribution of the
    [Show full text]